161Tb-NYM032
N/A
Report date: 2025/11/20 11:37:52
NME
Base Information
Drug Name161Tb-NYM032
Drug Alias Name
Classification +[4]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesWuxi Nuoyu Pharmaceutical Technology Co LtdMianyang Central HospitalInstitute Of Nuclear Physics And Chemistry Chinese Academy Of Engineering Physics
China Registration ClassN/A
Develop Information
Active CompaniesMianyang Central Hospital
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A